L-Carnitine.
May slightly boost fat loss and exercise performance, but effects are often subtle. Helps your body use fat for energy. More proven to reduce muscle damage and soreness from exercise.
Reviewed March 2026
- Category
- Amino acid
- Also filed under
- May support fat loss (modestly).May improve exercise performance and recovery (in some individuals).May have neuroprotective effects (ALCAR form).
What L-Carnitine is, and what it does.
- Does it work
- Maybe. The fat loss claims are seriously overhyped. The data on reducing muscle soreness is better. If that's your goal, it might be worth a shot.
- How much to take
- 1-2 grams daily. L-Carnitine L-Tartrate (LCLT) is the form studied for exercise. Acetyl-L-Carnitine (ALCAR) is for brain health.
- Time to feel it
- Muscle carnitine climbs slowly. Trials that raised it dosed daily for weeks, and the change turns up as less soreness after hard sessions rather than same-day.
- The first dose
- Nothing. This isn't a pre-workout. It needs weeks to build up in your system to have any effect.
- With regular use
- After a month, you might notice less muscle soreness and slightly better recovery between workouts. Any fat loss effect will be too small to notice without a spreadsheet.
- How well tolerated
- Generally well tolerated. The main issue is an upset stomach if you take too much. High doses (3g+) can also give you a fishy body odor. Seriously.
- How it feels
- You don't feel it. It's a background nutrient, not a stimulant. The effect is measured in reduced soreness, not a feeling.
- The overlooked benefit
- Its second job is buffering. It mops up acyl groups when they pile up faster than they burn and frees coenzyme A for other reactions, separate from the fat transport story.
500mg a day is where L-Carnitine works.
Source: Fielding 2018 + Ruggenenti 2009 kidney study
The proof, claim by claim.
These words describe the research, not the molecule's worth. Research strength is how much work stands behind one claim, and it is never a product score.
While L-Carnitine's role in fatty acid metabolism is well-established, the extent of its benefits as a supplement, especially for those without a deficiency, is debated. Research shows some promise, but results are often inconsistent and depend on the form and the individual.
- Modestly supports body weight reductionMeta-analysis of 9 RCTs (n=911)
- Reduces post-exercise muscle damage markers (creatine kinase)Meta-analysis of 16 RCTs
- Improves glycemic control (insulin resistance)Meta-analysis of 5 RCTs
Questions people ask about L-Carnitine.
- Will this actually help me lose weight?
- Barely. A large analysis found it adds about 2-3 pounds of extra weight loss over several months. Your diet and exercise are doing 99% of the work.
- Do I need to take it with food?
- It can help absorption a little and might be easier on your stomach. But consistency is more important than whether you take it with a meal.
- Is L-Carnitine vegan?
- Yes, the supplement version is made in a lab. Vegans often have lower carnitine levels, so they may see more benefit from supplementing.
- What's the 'fishy smell' side effect?
- At high doses (over 3 grams), your body can produce a compound that comes out in sweat and breath smelling like fish. If it happens, lower your dose.
- Can I just get it from food?
- You can, but you'd need to eat a ridiculous amount. A therapeutic dose is equal to about 4 pounds of steak. A supplement is the only practical way.
- When is the best time to take it?
- Doesn't matter much. Some people take it before a workout, but as long as you take it every day, you'll get the benefit.
What the trials show about these together.
Outcomes the engine found studied for these actives as a combination, not one at a time. Each is a finding a named trial measured, cited and dated, never written by the brand.
- EarlyL-Carnitine + CarbohydrateAbsorption
In two human studies, the first randomized, adding a carbohydrate drink to oral L-carnitine lowered 24-hour urinary carnitine excretion compared with L-carnitine alone, which the authors said suggests more of the dose was retained.
Stephens et al., 2006 (J Appl Physiol)PMID 17138832
Research strength. Research strength says how much work stands behind the combination. It is never a product score.
Fail closed. Where actives were studied on their own rather than together, the record shows each on its own evidence, never a combined effect no trial measured.
Independent record. Every finding is cited to a named trial, dated, and never written by the brand.
Findings from trials that studied these actives as a combination. Context for how the actives were tested together, not a statement about any individual and not a claim about this product.
Why these belong in the same formula. Each row says what the basis is, from settled biochemistry through to a trial that measured the pair.
The body builds its own carnitine from lysine and methionine through two hydroxylation steps, and the enzymes that run both steps use vitamin C as a required cofactor. Keeping vitamin C adequate lets that internal carnitine synthesis pathway run normally.
Carnitine carries long-chain fatty acids into the mitochondria for beta-oxidation, and the electrons that beta-oxidation releases are then shuttled through the respiratory chain by coenzyme Q10. The two act at consecutive stages of the same energy-production pathway, which is the long-standing reason mitochondrial energy formulas often combine them.
A fatty acid has to be activated by attaching it to coenzyme A, which the body makes from pantothenic acid, before carnitine can carry it into the mitochondria. Carnitine and coenzyme A then trade the fatty-acyl group back and forth across the mitochondrial membrane, so the two work in tandem to route fats toward energy production.
Choline supports fatty acid export as phosphatidylcholine in lipoproteins while carnitine moves fatty acids into the mitochondrion, two ends of the same lipid handling. Both are also trimethylamine-bearing molecules that gut bacteria convert, so the loads on that route add together.
Lipoic acid is the cofactor of the pyruvate and alpha-ketoglutarate dehydrogenase complexes that feed the citric acid cycle, while carnitine delivers fatty acid fuel to the same mitochondrion. The pair covers carbohydrate-derived and fat-derived fuel entry.
Endogenous carnitine is built from methylated lysine residues released by protein turnover. Lysine is the carbon skeleton the pathway begins with.
S-adenosyl methionine donates the three methyl groups that turn lysine into trimethyllysine, the true starting material. No methyl supply means no precursor.
Two hydroxylation steps in carnitine biosynthesis use iron-dependent dioxygenases that require ferrous iron. Iron status therefore limits how much carnitine the body can make itself.
The aldolase step in carnitine biosynthesis runs on pyridoxal phosphate. B6 sits inside the pathway rather than alongside it.
An NAD-dependent dehydrogenase step is needed to reach gamma-butyrobetaine on the way to carnitine, and niacin supplies that NAD. Niacin status feeds directly into biosynthesis.
Acyl-CoA dehydrogenases that start beta-oxidation after the shuttle delivers its cargo are FAD-dependent. Riboflavin supplies FAD, so it controls the step right after carnitine's job ends.
ALCAR is L-carnitine carrying an acetyl group and the two interconvert through carnitine acetyltransferase. The acetylated form crosses into the brain more readily, which is why formulas often carry both.
EPA and DHA are long-chain fatty acids and long-chain fatty acids need the carnitine shuttle to reach the mitochondrial matrix. Carrier and cargo meet at the same membrane step.
Betaine returns homocysteine to methionine and so refills the S-adenosyl methionine pool that carnitine biosynthesis spends. Both molecules also carry trimethylamine groups that gut bacteria act on, so those loads add.
The body builds carnitine from trimethyllysine, and those three methyl groups come from S-adenosylmethionine, which is made from methionine. Methionine supply therefore sits directly upstream of endogenous carnitine synthesis alongside lysine. This is pathway biochemistry rather than a tested pairing, and supplemental carnitine bypasses the whole synthesis route anyway.
Long-chain fatty acids cannot cross the inner mitochondrial membrane without the carnitine shuttle. Medium-chain fatty acids largely enter independently of that shuttle, which is the whole reason MCTs oxidise quickly. So the two ingredients address fat oxidation through different doors and MCT does not require carnitine to work. Worth stating precisely because the pair is often sold as one idea when the mechanisms barely overlap.
Endogenous carnitine synthesis starts from lysine residues already methylated within proteins, so total protein turnover feeds the pathway. Whey is dense in lysine and methionine, the two amino acids the pathway needs. That makes adequate protein intake a background condition for carnitine status rather than an additive supplement effect. Labelled Promising because the pathway is established while the practical size of the contribution from a protein supplement is not quantified.
Oral carnitine absorption is saturable, and whatever is not absorbed is metabolised by gut bacteria to trimethylamine, which the liver oxidises to trimethylamine N-oxide. Microbial composition determines how much of that conversion happens, so the bacterial community changes the metabolic fate of a carnitine dose. TMAO is a circulating marker studied for its associations, not a demonstrated outcome, and shifting it is not itself a benefit or a harm. Direction of effect from any given probiotic strain is not established.
A randomised trial gave alpha-linolenic acid and L-carnitine concurrently and reported changes in symptom and mental-health measures relative to control. Flaxseed oil is the usual dietary source of alpha-linolenic acid, which is why it is named as the partner here. The trial tested the combination rather than the two separately, so it cannot say which component carried the change. Outcomes were self-reported scales in a single trial population.
Both carnitine and taurine concentrate in skeletal and cardiac muscle and both are conditionally essential, so they appear together in the same product categories. That shared distribution is real; a shared mechanism is not established, and no trial of the pair is cited. Anyone reading this should regard it as a formulation pattern rather than a demonstrated interaction.
Caffeine increases circulating free fatty acids by stimulating lipolysis, and the carnitine shuttle is the step that carries long-chain fatty acids into the mitochondrion. On paper the two sit in sequence, which is why they are formulated together. No cited trial tests the sequence in people, and supplemental carnitine raises muscle carnitine content only slowly and under specific conditions. Early is the honest confidence.
Talk to a doctor before taking L-Carnitine if any of these apply to you: May cause gastrointestinal distress in some individuals (nausea, vomiting, diarrhea), Individuals with kidney problems should consult a doctor before using, May interact with certain medications, such as blood thinners. These are flags to check first, not effects L-Carnitine is known to cause.
Not medical advice. Show the label to your pharmacist.What L-Carnitine actually does.
Carnitine is the ferry that carries long-chain fats into the part of the cell that burns them for energy.
Carnitine soaks up excess fat fragments and carries them out in urine, keeping the cell's handling molecule available.
The body can make its own carnitine from methylated lysine, using iron and vitamin C, and the last step happens only in the liver and kidneys.
A specific transporter pulls carnitine into cells, and the same transporter lets the kidneys reclaim it instead of losing it in urine.
Where L-Carnitine comes from.
It is made in a factory, either by chemistry followed by separating out the wrong-handed version, or by an enzyme that only makes the right-handed one. Then it is purified and often turned into a less sticky salt.
Chemically synthesised. The molecule is identical to the one a plant or an animal makes, and building it deliberately means a known purity, a fixed dose and no crop contaminants. For several nutrients this is the only route that reaches a usable amount.
The common industrial routes start from epichlorohydrin with trimethylamine and a cyanide source, or from crotonobetaine derived from betaine chemistry. None of these is a food-derived feedstock.
Straight chemical synthesis produces the racemic DL mixture. Because D-carnitine competes with the active L form, the racemate has to be resolved, classically by forming a salt with a chiral acid and crystallising one diastereomer selectively.
An alternative industrial route uses a microbial carnitine dehydratase to hydrate crotonobetaine directly to L-carnitine. This route does not form the unwanted enantiomer, so no separation step is needed.
The L-carnitine is purified by ion exchange and crystallised as the inner salt, then assayed for enantiomeric purity, which is the critical specification for this ingredient.
The free inner salt is strongly hygroscopic, so it is often converted to L-carnitine L-tartrate or fumarate for tablets and powders, or acylated to acetyl or propionyl derivatives for different tissue-distribution profiles.
Labels rarely state which route was used, the enantiomeric purity achieved, or how much of the declared weight is the tartrate or fumarate counter-ion rather than carnitine.
Getting L-Carnitine from food.
The whole-food sources on file. A supplement closes the gap, it does not replace dinner.
A gram-for-gram figure (how much of each you would eat to match a dose) will appear here once it is sourced and reviewed. This page will not print a number it cannot cite.
The forms it comes in.
The essence, in one line each.
- Pooling 37 randomized trials, L-carnitine was linked to a modest reduction in body weight of about 1.2 kg and in fat mass of about 2.1 kg, mainly in adults with overweight.Meta-analysis. Talenezhad et al., 2020 (Clinical Nutrition ESPEN). PMID 32359762 ↗
- In a meta-analysis of randomized trials, carnitine supplementation raised sperm total motility by about 7.8 percentage points, progressive motility by about 7.5 points, and normal morphology by about 4.9 points.Meta-analysis. Salas-Huetos et al., 2018 (Advances in Nutrition). PMID 30462179 ↗
- Across seven randomized trials, L-carnitine reduced exercise-induced muscle soreness and lowered 24-hour blood markers of muscle damage (creatine kinase, myoglobin and lactate dehydrogenase).Meta-analysis. Yarizadh et al., 2020 (Journal of the American College of Nutrition). PMID 32154768 ↗
- Pooling eight meta-analyses covering 16,352 adults on 150 to 4000 mg a day, L-carnitine was linked to small reductions in body weight, body mass index (effect size -0.33) and waist circumference (effect size -1.34).Meta-analysis. Hamedi-Kalajahi et al., 2025 (Int J Vitam Nutr Res). PMID 40298161 ↗
- Across thirteen earlier meta-analyses, L-carnitine at more than 2 g a day was associated with lower LDL cholesterol (about -4.8 mg/dL), triglycerides (about -2.5 mg/dL) and total cholesterol, and slightly higher HDL cholesterol.Meta-analysis. Musazadeh et al., 2023 (Front Nutr). PMID 37727632 ↗
- Across 15 trials, L-carnitine was associated with lower fasting blood glucose (about -4.9 mg/dL), lower fasting insulin (about -1.0 microunit/mL) and a lower insulin resistance index (-0.58), with no detectable change in HDL cholesterol.Meta-analysis. Li et al., 2023 (Food Funct). PMID 36815696 ↗
- Pooling 48 randomised trials in 3,255 adults, L-carnitine lowered the blood markers C-reactive protein and interleukin-6 and raised total antioxidant capacity, with the clearest signal in trials lasting 12 weeks or longer; these are markers rather than measured outcomes.Meta-analysis. Rastgoo et al., 2023 (Inflammopharmacology). PMID 37656233 ↗
- Across 22 randomised trials in 1,412 adults, L-carnitine did not measurably change systolic blood pressure (-1.22 mmHg, confidence interval -3.79 to 1.35), and a small diastolic reduction of about 1.6 mmHg appeared only in participants starting above a body mass index of 30.Meta-analysis. Anaraki et al., 2024 (Clin Ther). PMID 38101999 ↗
- In 20 trained recreational athletes, a single 3 g dose of L-carnitine tartrate 90 minutes before a high-intensity workout did not measurably change repetitions completed (202.4 versus 204.5, p = 0.81) or perceived exertion.Randomised trial. Devrim-Lanpir et al., 2025 (Nutrients). PMID 40944177 ↗
- Pooled trials of L-carnitine in adults receiving haemodialysis and reported the measured cardiac function parameters, a population in which carnitine is lost across the dialysis membrane.Systematic review. Nabi et al., 2025 (International Urology and Nephrology). PMID 40172612 ↗
- A systematic review and meta-analysis of L-carnitine supplementation against cardiac and metabolic risk markers in adults on haemodialysis; the pooled outcomes are blood and imaging markers.Systematic review. Vajdi et al., 2026 (BMC Nephrology). PMID 42316068 ↗
- Pooled the effect of L-carnitine on blood lipid measures in adults undergoing haemodialysis; lipid fractions are markers rather than clinical events.Systematic review. Karimi et al., 2024 (Frontiers in Medicine). PMID 39687901 ↗
- A systematic review and meta-analysis of L-carnitine supplementation on lipid profile parameters in women with excess body weight; the pooled measures are circulating lipid markers.Systematic review. Yu et al., 2026 (Nutrition and Metabolism). PMID 42332819 ↗
- Reviewed the trial literature on L-carnitine supplementation in adults with age-related joint wear and summarised the reported changes in joint comfort and inflammatory markers; the number of eligible trials is small.Systematic review. Kou et al., 2024 (Molecular Nutrition and Food Research). PMID 38389158 ↗
- Pooled trials of L-carnitine in critically ill patients and reported the inflammatory and oxidative stress markers alongside clinical measures; an intensive-care population, which does not transfer to general supplement use.Systematic review. Keshani et al., 2024 (Nutrition Journal). PMID 38444016 ↗
- Reviewed L-carnitine supplementation in adults awaiting liver transplant who had low muscle mass and summarised the reported post-transplant measures; a narrow surgical population.Systematic review. El-Razek Salama et al., 2025 (Clinical Nutrition ESPEN). PMID 40962224 ↗
- Measured gastric emptying and bowel function in children on ketogenic diet therapy given L-carnitine, a group in which carnitine handling is already altered by the diet's high fat load.Randomised trial. Nassar et al., 2024 (Scientific Reports). PMID 39543202 ↗
- Tested L-carnitine against rate of weight gain and gut-function biomarkers in a paediatric growth setting; the biomarkers are intestinal permeability and inflammation measures, not clinical endpoints.Randomised trial. Alam et al., 2024 (The Journal of Nutrition). PMID 38331348 ↗
- Gave alpha-linolenic acid and L-carnitine concurrently and reported changes in symptom scores and mental-health measures; because the two were given together the trial cannot attribute the change to either alone.Randomised trial. Golpour-Hamedani et al., 2025 (Nutrition Journal). PMID 40082970 ↗
- A small pilot study of L-carnitine in adults with a mild to moderate acute viral respiratory infection; a pilot is sized to test feasibility, so it does not establish an effect.Open-label trial. Talebi et al., 2022 (Pharmacological Reports). PMID 35997951 ↗
- Rumen-protected L-carnitine fed during the mating period altered metabolic status and reproductive performance measures in sheep; a livestock result that supports carnitine's role in energy metabolism without transferring to people.Animal study. Masoomi et al., 2024 (Journal of Animal Physiology and Animal Nutrition). PMID 37867377 ↗
- Dietary L-carnitine was associated with differences in ovarian follicular development in ewes under a subclinical metabolic challenge; an animal reproductive-tissue association.Animal study. Turgut et al., 2026 (Archives Animal Breeding). PMID 42088855 ↗
- Alpha-lipoic acid, betaine and L-carnitine given together changed gut microbiota composition and body-composition biomarkers in mice; a three-ingredient combination in rodents, so it cannot isolate carnitine or speak to human dosing.Animal study. Kim et al., 2026 (Nutrients). PMID 41901100 ↗
These are the studies our verdict leans on, chosen from the 2,616 we read for L-Carnitine. The full linked list is below.
The studies, linked.
12 sources behind our L-Carnitine verdict: peer-reviewed studies and registered clinical trials. Every one links straight to PubMed, the journal, or ClinicalTrials.gov. Read them yourself.
- Clinical trialA Prospective, Randomized, Double-blind, Placebo-controlled Trial to Evaluate the Effect of 6-month Acetylcarnitine Therapy on Arterial Blood Pressure, Lipid and Metabolic Profile, and Kidney Function in Hypertensive Patients With Type 2 Diabetes on Background Simvastatin TherapyClinicalTrials.gov ↗PHASE3 · 229 participants · Completed
- Clinical trialN-Acetylcysteine Versus L-carnitine in Clomiphene Citrate Resistant Pcos Women. a Randomized Controlled TrialClinicalTrials.gov ↗PHASE2 · 164 participants · Completed
- Clinical trialEffects of Triple Drug Cocktail Therapy on Metabolic, Endocrine Alterations and Perceived Stress Response in Patients With PCOS: A Double Blind Randomized Clinical TrialClinicalTrials.gov ↗PHASE2 · 147 participants · Completed
- Clinical trialEarly Administration of L-carnitine in Hemodialysis Patients: Double Blind Randomized Trial Versus PlaceboClinicalTrials.gov ↗PHASE3 · 110 participants · Completed
- Clinical trialPhase II Developmental Study on Fatigue in AIDS PatientsClinicalTrials.gov ↗PHASE2 · 44 participants · Completed
- Clinical trialThe Use of a Mitochondrial Enhancement Treatment in Bipolar Disorder: A Randomized, Placebo-Controlled Trial of Acetyl-L-Carnitine and Alpha-Lipoic Acid for the Treatment of Bipolar DepressionClinicalTrials.gov ↗PHASE2 · 40 participants · Completed
- Clinical trialMitochondrial Cofactors for the Treatment of Hyperbilirubinemia Due to PEG-Asparaginase and or Inotuzumab Ozogamicin in Patients With Acute Lymphoblastic Leukemia (ALL)ClinicalTrials.gov ↗PHASE2 · 10 participants · Terminated
- Clinical trialComparison the Effectiveness of L-Carnitine With Atorvastatin in Non-Alcoholic Steatohepatitis (NASH)ClinicalTrials.gov ↗PHASE2 · 440 participants · Unknown
- Clinical trialA Study to Evaluate the Efficacy and Safety of HSK16149 Capsule Combined With L-carnitine Hydrochloride Tablets and Lipoic Acid Combined With L-carnitine Hydrochloride Tablets in Diabetic Peripheral Neuralgia Patients in ChinaClinicalTrials.gov ↗NA · 136 participants · Unknown
- Clinical trialRole of Nutritional Support in Idiopathic Male Infertility: a Randomized Dietary StudyClinicalTrials.gov ↗NA · 100 participants · Unknown
- Clinical trialEffect of Levocarnitine Injections on Reducing Erythropoietin-Stimulating Agent Requirements in Hemodialysis Patients With Renal AnemiaClinicalTrials.gov ↗PHASE4 · 94 participants · Not yet recruiting
- Clinical trialMatching Perfusion and Metabolic Activity in HFpEFClinicalTrials.gov ↗PHASE2 · 53 participants · Recruiting
Evidence surfaced via Semantic Scholar (Allen Institute for AI) and ClinicalTrials.gov. Ranked by study type and citation weight, not cherry-picked.
Problems people have reported.
Read this carefully. These are 2,807 voluntary, unverified reactions reported to the FDA (openFDA). The number mostly reflects how popular L-Carnitine is, not how risky it is. A report is not proof L-Carnitine caused anything. It is a signal of what to watch for, nothing more.
Source: openFDA adverse-event reports. Voluntary reporting, not an incidence rate.
FDA Disclaimer: These statements have not been evaluated by the Food and Drug Administration. This information is for educational purposes only and is not intended to diagnose, treat, cure, or prevent any disease. Consult your healthcare provider before starting any supplement regimen.





